BiomX to Report Fourth Quarter and Full Year 2020 Financial Results on March 31, 2021

Rhea-AI Summary

BiomX (NYSE American: PHGE) plans to host a conference call on March 31, 2021, at 8:00 a.m. EDT to discuss its fourth quarter and full year 2020 financial results. The call will be accessible via phone and an archived webcast will be available on their website. BiomX specializes in developing phage therapies targeting pathogenic bacteria linked to skin conditions and chronic diseases, including inflammatory bowel disease and colorectal cancer. Their innovations focus on creating customized phage cocktails to effectively combat these bacterial targets.

Positive

• BiomX is advancing innovative phage therapies targeting specific pathogenic bacteria.
• The company focuses on chronic diseases and skin conditions with significant market potential.

Negative

• No specific financial metrics or results were disclosed in the PR.

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and live audio webcast on Wednesday, March 31, 2021, at 8:00 a.m. EDT, to report fourth quarter and full year 2020 financial results. To participate in the conference call, please dial 1-877-407-0724 (U.S.), 1-809-406-247 (Israel) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.

About BiomX

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005132/en/

FAQ

When is BiomX's conference call to report 2020 financial results?

BiomX will host the conference call on March 31, 2021, at 8:00 a.m. EDT.

How can I access the BiomX conference call?

You can participate by dialing 1-877-407-0724 (U.S.) or accessing the live audio webcast on their website.

What is BiomX's focus in microbial therapy?

BiomX develops natural and engineered phage cocktails targeting pathogenic bacteria related to skin and chronic diseases.

What diseases does BiomX target with its therapies?

BiomX targets conditions like inflammatory bowel disease, cystic fibrosis, and colorectal cancer.